Projects per year
Abstract
AKT is the central phosphoinositide 3-kinase (PI3K) signaling effector, however, PIK3CA (p110α subunit of PI3Kα)-mutant estrogen receptor-positive (ER+) breast cancers exhibit minimal AKT activation and the downstream signaling is poorly characterized. We discovered that a subset of PIK3CA-mutant ER+ breast cancers exhibit increased inositol polyphosphate 4-phosphatase type II (INPP4B) expression, which promotes late endosome formation and glycogen synthase kinase 3 beta (GSK3β) trafficking, leading to enhanced Wingless–related integration site (WNT)/catenin beta 1 (β-catenin) activation.
| Original language | English |
|---|---|
| Article number | 1954470 |
| Number of pages | 3 |
| Journal | Molecular and Cellular Oncology |
| Volume | 8 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2021 |
Keywords
- cell proliferation
- INPP4B
- late endosome
- PIK3CA
- WNT/β-catenin
Projects
- 1 Finished
-
Characterisation of a novel oncogene in breast cancer
Mitchell, C. (Primary Chief Investigator (PCI)), Ellisdon, A. (Chief Investigator (CI)) & McLean, C. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/16 → 31/12/21
Project: Research